We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

22 hedge funds and large institutions have $2.28M invested in Vaccinex, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

19% less funds holding

Funds holding: 27 → 22 (-5)

55% less capital invested

Capital invested by funds: $5.03M → $2.28M (-$2.75M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
10
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$55.7K
2
Citadel Advisors
Citadel Advisors
Florida
+$39.5K
3
Simplex Trading
Simplex Trading
Illinois
+$20.4K
4
Group One Trading
Group One Trading
Illinois
+$14.5K
5
Northern Trust
Northern Trust
Illinois
+$5.69K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$75.6K
2
TSS
Two Sigma Securities
New York
-$59K
3
Goldman Sachs
Goldman Sachs
New York
-$24K
4
BlackRock
BlackRock
New York
-$12.8K
5
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$5K

VCNX Hedge Fund Activity: Q3 2022 in Review

22 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q3 2022, worth a combined $2.28M — down 55% from $5.03M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VCNX and 0 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 10 added.

The largest buyer was Susquehanna International Group, adding an estimated $55.7K. The largest seller was Millennium Management, cutting an estimated $75.6K.

  • 22 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q3 2022, down from 27 in Q2 2022.
  • Funds reported $2.28M of Vaccinex, Inc. Common Stock stock for Q3 2022, down 55% quarter-over-quarter.
  • 0 funds opened new Vaccinex, Inc. Common Stock positions in Q3 2022 and 5 closed out, a net change of -5 holders.
  • The largest Vaccinex, Inc. Common Stock buyer in Q3 2022 was Susquehanna International Group, an estimated $55.7K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q3 2022 was Millennium Management, an estimated $75.6K sold.

Based on aggregated 13F filings for Q3 2022.